TSHA Competitors & Alternatives
Compare Taysha Gene Therapies Inc with similar stocks in the same industry
Biotechnology
TSHA
Main Stock$6.03
Tradestie Score
51
Market Cap
$867.49M
Revenue Growth
1.7%
Analyst Upside
+119.7%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$32.80
|
$1.81B | - | 55 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$6.10
|
$1.78B | - | 55 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$25.77
|
$1.78B | - | 54 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$20.33
|
$1.74B | - | 61 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$38.76
|
$1.68B | - | 60 | Compare |
|
MNKD
Mannkind Corporation
|
$3.94
|
$1.65B | - | 48 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$43.60
|
$1.63B | - | 51 | Compare |
|
BHVN
Biohaven Ltd.
|
$13.48
|
$1.57B | - | 51 | Compare |
|
VCEL
Vericel Corporation
|
$46.16
|
$1.56B | 95.8 | 58 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$109.32
|
$1.55B | - | 54 | Compare |
More TSHA Analysis
Data updated: Aug 04, 2026 | Industry: Biotechnology (SIC 2836)
229 stocks in this industry